Invest Like The Best
Episode 360 Unlocking Innovation in Pharma
Invest Like The Best

Episode 360: Unlocking Innovation in Pharma

Invest Like The Best

Episode 360

Unlocking Innovation in Pharma

Alex Telford is the founder of Convoke. We cover the ins and outs of developing and pricing new drugs, what can be done to shorten the time it takes to bring drugs to market, and why AI won't be a silver bullet for the industry.

This episode is brought to you by:

Tegus. Tegus is the modern research platform for leading investors. Stretch your research budget with flexible expert calls you can trust. As a listener, you can trial Tegus for free by visiting tegus.co/patrick.

 

(00:00:31) - (first question) Exploring public perceptions of Big Pharma

(00:01:26) - Providing an overview of the drug discovery process

(00:03:52) - Assessing the efficiency of the pharmaceutical industry

(00:08:43) - Anticipating the future direction of drug development

(00:13:16) - Categorizing different types of pharmaceutical drugs

(00:17:49) - Strategies to reduce time from discovery to implementation

(00:22:25) - Gaining insights from cross-disciplinary research

(00:27:43) - The emerging role of AI in pharmaceuticals

(00:31:02) - Analyzing potential regulatory shifts in the industry

(00:35:43) - Discussing the importance of Randomized Controlled Trials (RCTs)

(00:40:59) - Examining the impact of blockbuster drugs

(00:44:17) - Deliberating on the complexities of drug pricing

(00:50:39) - Highlighting exciting developments and concerns in pharma

(00:56:25) - The kindest thing anyone has ever done for him

 

Unlocking Innovation in Pharma

Introduction

Patrick
My guest today is Alex Telford. Alex is the founder of Convoke, a software platform that helps streamline drug development and commercialization. He has also been writing frequent blog posts on the biotech industry since 2019, keeping a pulse on the direction of innovation. He joined me today to talk about the history of the pharmaceutical industry and what's becoming possible in medicine in the coming years.

Alex helped breakdown the complexities of investing in new drug development, breakthroughs in gene therapy on the horizon and the dance between timely progress and restrictive regulation. This industry has a ton to unpack, and Alex thoughtfully lays out the landscape. Please enjoy my conversation with Alex Telford.

How Drugs Are Developed

Patrick
Alex, we're going to spend a ton of time today talking about pharmaceuticals, not just the industry, some of the companies, but the process by which the world has created incredible technologies for our health and also the impediments to creating more of them in the future. Can you give your version of just a sweeping overview of the process and evolution of how we find drugs?

Access the full transcript
Sign in or register to view episode transcripts.

Contact

Get in touch at help@joincollossus.com